Themes US R&D Champions ETFUSRDETF
13F holders, Q1 2025 (March 31)2holders
0new positions
0sold out
$27.60avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Themes US R&D Champions ETF (USRD) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Geneos Wealth Management Inc. ($18K) and UBS Group AG ($911).
- Company
- Themes US R&D Champions ETF
- CUSIP
- 882927874
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Geneos Wealth Management Inc. | 0.00% | No change | 650 | $18K |
| UBS Group AG | 0.00% | No change | 33 | $911 |
"% of holder's portfolio" is USRD's weight in each manager's 13F, not the share of Themes US R&D Champions ETF the manager owns.